Bookmark Article
Telehealth and wellness platform Hims & Hers gave a strong revenue outlook for the upcoming year, surpassing Wall Street’s expectations. However, the company’s shares experienced a significant drop in after-hours trading, following a sell-off on Friday related to concerns about the future of its Ozempic alternatives.
Full Article
